CD36 indeed plays a central role in the development of NAFLD, notably by promoting hepatic de novo lipogenesis (66), and its hepatocyte-specific deletion attenuates fatty liver in HFD-fed mice (67). The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.